GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » Gross Profit

RaySearch Laboratories AB (OSTO:RAY B) Gross Profit : kr943 Mil (TTM As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB Gross Profit?

RaySearch Laboratories AB's gross profit for the three months ended in Mar. 2024 was kr234 Mil. RaySearch Laboratories AB's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was kr943 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. RaySearch Laboratories AB's gross profit for the three months ended in Mar. 2024 was kr234 Mil. RaySearch Laboratories AB's Revenue for the three months ended in Mar. 2024 was kr257 Mil. Therefore, RaySearch Laboratories AB's Gross Margin % for the quarter that ended in Mar. 2024 was 91.02%.

RaySearch Laboratories AB had a gross margin of 91.02% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of RaySearch Laboratories AB was 95.92%. The lowest was 88.74%. And the median was 92.75%.


RaySearch Laboratories AB Gross Profit Historical Data

The historical data trend for RaySearch Laboratories AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Gross Profit Chart

RaySearch Laboratories AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 669.22 608.24 591.28 748.66 915.58

RaySearch Laboratories AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 206.25 217.44 222.05 269.84 234.09

Competitive Comparison of RaySearch Laboratories AB's Gross Profit

For the Health Information Services subindustry, RaySearch Laboratories AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Gross Profit falls into.



RaySearch Laboratories AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

RaySearch Laboratories AB's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=1022.159 - 106.578
=916

RaySearch Laboratories AB's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=257.196 - 23.102
=234

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr943 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

RaySearch Laboratories AB's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=234 / 257.196
=91.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


RaySearch Laboratories AB  (OSTO:RAY B) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

RaySearch Laboratories AB had a gross margin of 91.02% for the quarter that ended in Mar. 2024 => Durable competitive advantage


RaySearch Laboratories AB Gross Profit Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB (OSTO:RAY B) Business Description

Traded in Other Exchanges
Address
Sveavagen 44, P.O. Box 3297, Stockholm, SWE, 103 65
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB (OSTO:RAY B) Headlines

No Headlines